ISSN 1004-4140
CN 11-3017/P

AAV-ILD的CT影像学特征与ANCA浓度的相关性分析研究

王红梅, 李俊林, 董宇清, 张月阳, 姚韧寰

王红梅, 李俊林, 董宇清, 等. AAV-ILD的CT影像学特征与ANCA浓度的相关性分析研究[J]. CT理论与应用研究(中英文), 2025, 34(4): 604-610. DOI: 10.15953/j.ctta.2025.081.
引用本文: 王红梅, 李俊林, 董宇清, 等. AAV-ILD的CT影像学特征与ANCA浓度的相关性分析研究[J]. CT理论与应用研究(中英文), 2025, 34(4): 604-610. DOI: 10.15953/j.ctta.2025.081.
WANG H M, LI J L, DONG Y Q, et al. Computer Tomography Features of Antineutrophil Cytoplasm Antibody-associated Vasculitis-interstitial Lung Disease and Its Correlation with Antineutrophil Cytoplasmic Antibody Concentration[J]. CT Theory and Applications, 2025, 34(4): 604-610. DOI: 10.15953/j.ctta.2025.081. (in Chinese).
Citation: WANG H M, LI J L, DONG Y Q, et al. Computer Tomography Features of Antineutrophil Cytoplasm Antibody-associated Vasculitis-interstitial Lung Disease and Its Correlation with Antineutrophil Cytoplasmic Antibody Concentration[J]. CT Theory and Applications, 2025, 34(4): 604-610. DOI: 10.15953/j.ctta.2025.081. (in Chinese).

AAV-ILD的CT影像学特征与ANCA浓度的相关性分析研究

基金项目: 

内蒙古医学科学院公立医院科研联合基金科技项目(2024GLLH0033;2023GLLH0030)。

详细信息
    作者简介:

    王红梅,博士,副主任医师,擅长中枢、胸部及腹部疾病影像诊断,E-mail:xjtuwhm@163.com

    通讯作者:

    姚韧寰✉,硕士,副主任医师,擅长核医学诊断及治疗,E-mail:493769809@qq.com

  • 中图分类号: R 537;R 814

Computer Tomography Features of Antineutrophil Cytoplasm Antibody-associated Vasculitis-interstitial Lung Disease and Its Correlation with Antineutrophil Cytoplasmic Antibody Concentration

  • 摘要:

    本研究旨在系统分析抗中性粒细胞胞浆抗体相关性血管炎(AAV)−间质性肺病(ILD)患者首次诊断时的CT影像学特征,探讨病变类型、分布特点及其与实验室检查结果的相关性。回顾性纳入92例首次确诊为AAV-ILD的患者,收集患者的临床及CT影像数据,对CT影像资料进行主观定量分析,评估病变类型(如磨玻璃影、网格影、蜂窝样改变、实变影及牵拉性支气管扩张)及其分布特征。采用肺纤维化评分系统量化病变严重程度,分析影像学特征ANCA浓度之间的相关性。结果发现AAV-ILD在老年男性中更为常见,蜂窝样改变和网格影是最常见的影像学表现,病变主要分布于双肺下叶及外周区域,主要表现为寻常型间质性肺炎(UIP)模式。另外还发现肺纤维化评分与髓过氧化物酶(MPO)浓度呈显著正相关,蜂窝样改变评分与MPO浓度也存在正相关。AAV-ILD的CT表现具有独特的特点,而且MPO-ANCA与肺纤维化的相关性提示MPO可能成为肺纤维化进展的潜在生物标志物,这为深入理解AAV-ILD的影像学特征及其病理机制提供了重要依据。

    Abstract:

    This study systematically analyzed the CT imaging features of patients diagnosed with ANCA-associated vasculitis (AAV)-related interstitial lung disease (ILD) at the time of their first diagnosis. The types and distribution characteristics of the lesions and their correlation with laboratory findings were investigated. A retrospective study was conducted on 92 patients with newly diagnosed AAV-ILD. Clinical and CT imaging data were collected. CT imaging data were analyzed qualitatively and quantitatively to evaluate lesion types (e.g., ground-glass opacities, reticulations, honeycombing, consolidation, and traction bronchiectasis) and their distribution patterns. The severity of the lesions was quantified using a pulmonary fibrosis scoring system, and the correlation between imaging features and laboratory indices was analyzed. AAV-ILD was more commonly observed in elderly male patients. Honeycombing and reticulations were the most common CT-imaging findings, with lesions primarily distributed in the bilateral lower lungs and peripheral regions. AAV-ILD predominantly exhibited a usual interstitial pneumonia (UIP) pattern. A significant positive correlation was also observed between the pulmonary fibrosis score and myeloperoxidase (MPO) concentration and between honeycombing scores and MPO concentration. The CT features of AAV-ILD are unique. The correlation between MPO and pulmonary fibrosis suggests that MPO may serve as a potential biomarker for the progression of pulmonary fibrosis. These findings provide important insights into the imaging characteristics and pathological mechanisms of AAV-ILD.

  • 图  1   AAV-ILD患者肺部UIP和NSIP模式

    注:(a)男,57岁,临床确诊AAV,双肺多发蜂窝样改变伴牵拉性支气管扩张,符合典型UIP模式。(b)女,65岁,临床确诊AAV,双肺胸膜下磨玻璃密度影及小叶间隔增厚,胸膜下不受累,符合NSIP模式。

    Figure  1.   Pulmonary UIP and NSIP patterns in patients with AAV-ILD

    图  2   纤维化评分与MPO-ANCA相关性分析结果

    Figure  2.   Correlation analysis between AAV-ILD pulmonary fibrosis score and MPO-ANCA

    表  1   AAV-ILD患者临床特征

    Table  1   Clinical characteristics of patients with AAV-ILD

    项目 临床特征 例数 占比/%
    总例数 92 100
    性别 54 58.7
    38 41.3
    吸烟史 有长期吸烟者≥10年12例 30 32.6
    62 67.4
    症状 咳嗽(干咳) 50 54.4
    气促(劳力性呼吸困难) 40 43.5
    胸痛 8 8.7
    咯血 5 5.4
    下载: 导出CSV

    表  2   AAV-ILD患者肺部HRCT特征

    Table  2   HRCT characteristics of lungs in patients with AAV-ILD

    项目 HRCT特征 例数 占比/%
    总例数 92 100
    影像学表现 蜂窝样改变(下叶分布为主) 78 84.8
    磨玻璃密度影 72 78.3
    实变影 6 6.5
    网格影 85 92.4
    牵拉性支气管扩张 72 78.3
    分布特点 外周分布 70 76.1
    弥漫性分布 22 23.9
    分布模式 UIP 62 67.4
    NSIP 15 16.3
    OP 10 10.9
    DAD 4 4.4
    NSIP叠加DAD 1 1.1
    下载: 导出CSV
  • [1]

    SEBASTIANI M, MANFREDI A, VACCHI C, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis[J]. Clinical and Experimental Rheumatology, 2020, 124(2): 221-231.

    [2]

    SACOTO G, BOUKHLAL S, SPECKS U, et al. Lung involvement in ANCA-associated vasculitis[J]. Presse Médicale, 2020, 49(3): 104039. DOI: 10.1016/j.lpm.2020.104039.

    [3] 刘泠钰, 田新平. 原发性系统性血管炎的肺部表现[J]. 中华医学杂志, 2021, 101(24): 1938-1941.

    LIU L Y, TIAN X P. Pulmonary manifestations of primary systemic vasculitis. Chinese Medical Journal, 2021, 101(24): 1938-1941. (in Chinese).

    [4]

    DOLINER B, RODRIGUEZ K, MONTESI S B, et al. Interstitial lung disease in ANCA-associated vasculitis: Associated factors, radiographic features and mortality[J]. Rheumatology (Oxford), 2023, 62(2): 716-725. DOI: 10.1093/rheumatology/keac339.

    [5] 马震忠, 盛亚丹, 杨凯, 等. 皮肌炎/多发性肌炎相关间质性肺病高分辨率CT特征[J]. CT理论与应用研究(中英文), 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131.

    MA Z Z, SHENG Y D, YANG K, et al. HRCT features of dermatomyositis-/polymyositis- associated interstitial lung disease[J]. CT Theory and Applications, 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131. (in Chinese).

    [6]

    HINO T, LEE KS, YOO H, et al. Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)[J]. European Journal of Radiology Open, 2021, 8: 100336. DOI: 10.1016/j.ejro.2021.100336.

    [7]

    DELANEY L, ALABED S, MAITER A, et al. Meta-analysis of interobserver agreement in assessment of interstitial lung disease using high-resolution CT[J]. Radiology, 2024, 313(1): e240016. DOI: 10.1148/radiol.240016.

    [8]

    TURGEON D, BALTER M S, PAGNOUX C. Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: An update on pathogenesis and treatment[J]. Current Opinion in Pulmonary Medicine, 2023, 29(5): 436-442. DOI: 10.1097/mcp.0000000000000979.

    [9]

    ALBA M A, FLORES-SUÁREZ L F, HENDERSON A G, et al. Interstitial lung disease in ANCA vasculitis[J]. Autoimmunity Reviews, 2017, 16(7): 722-729. DOI: 10.1016/j.autrev.2017.05.008.

    [10]

    MCDERMOTT G, FU X, STONE J H, et al. Association of cigarette smoking with antineutrophil cytoplasmic antibody-associated vasculitis[J]. JAMA Internal Medicine, 2020, 180(6): 870-876. DOI: 10.1001/jamainternmed.2020.0675.

    [11]

    CERRO-CHIANG G, AYRES M, RIVAS A, et al. An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease[J]. BMC Pulmonary Medicine, 2025, 25(1): 16. DOI: 10.1186/s12890-024-03474-z.

    [12]

    HUNNINGHAKE G M, HATABU H, OKAJIMA Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities[J]. New England Journal of Medicine, 2013, 368(23): 2192-2200. DOI: 10.1056/NEJMoa1216076.

    [13]

    CHOI W I, DAUTI S, KIM H J, et al. Risk factors for interstitial lung disease: A 9-year nationwide population-based study[J]. BMC Pulmonary Medicine, 2018, 18(1): 96. DOI: 10.1186/s12890-018-0660-2.

    [14]

    KADURA S, RAGHU G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: A review[J]. European Respiratory Review, 2021, 30(162). DOI: 10.1183/16000617.0123-2021.

    [15]

    OIWA H, OOI K, OYAMA T, et al. Idiopathic interstitial pneumonia as a possible cause of antineutrophil cytoplasmic antibody-associated vasculitis: A case report[J]. Archives of Rheumatology, 2018, 33(1): 89-92. DOI: 10.5606/ArchRheumatol.2018.6532.

    [16]

    NEGREROS M, FLORES-SUÁREZ L F. A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis[J]. Autoimmunity Reviews, 2021, 20(4): 102781. DOI: 10.1016/j.autrev.2021.102781.

    [17]

    LEE KS, HAN J, WADA N, et al. Imaging of pulmonary fibrosis: An update, from the AJR special series on imaging of fibrosis[J]. American Journal of Roentgenology, 2024, 222(2): e2329119. DOI: 10.2214/ajr.23.29119.

    [18]

    WIJSENBEEK M, SUZUKI A, MAHER T M. Interstitial lung diseases[J]. Lancet, 2022, 400(10354): 769-786. DOI: 10.1016/s0140-6736(22)01052-2.

    [19]

    BANKIER A A, MACMAHON H, COLBY T, et al. Fleischner society: Glossary of terms for thoracic imaging[J]. Radiology, 2024, 310(2): e232558. DOI: 10.1148/radiol.232558.

    [20]

    HATA A, HINO T, PUTMAN R K, et al. Traction bronchiectasis/bronchiolectasis on CT scans in relationship to clinical outcomes and mortality: The COPD Gene study[J]. Radiology, 2022, 304(3): 694-701. DOI: 10.1148/radiol.212584.

    [21]

    SMITH M L. The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis: Where we are and where we need to go[J]. Modern Pathology, 2022, 35(S1): 8-14. DOI: 10.1038/s41379-021-00889-5.

    [22] 张笑雨, 于文成, 冯爱然, 等. ANCA血管炎相关间质性肺病的研究进展[J]. 青岛大学学报(医学版), 2018, 54(1): 115-118,126.

    ZHANG X Y, YU W C, FENG A R, et al. Research progress of ANCA vasculitis-related interstitial lung disease[J]. Journal of Qingdao University (Med Edition), 2018, 54(1): 115-118,126. (in Chinese).

    [23]

    SALVATI L, PALTERER B, LAZZERI E, et al. Presentation and progression of MPO-ANCA interstitial lung disease[J]. Journal of Translational Autoimmunity, 2024, 8: 100235. DOI: 10.1016/j.jtauto.2024.100235.

    [24]

    HOSODA C, BABA T, HAGIWARA E, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis[J]. Respirology, 2016, 21(5): 920-926. DOI: 10.1111/resp.12763.

  • 期刊类型引用(0)

    其他类型引用(1)

图(2)  /  表(2)
计量
  • 文章访问数:  48
  • HTML全文浏览量:  4
  • PDF下载量:  2
  • 被引次数: 1
出版历程
  • 收稿日期:  2025-03-05
  • 修回日期:  2025-04-11
  • 录用日期:  2025-05-06
  • 网络出版日期:  2025-05-27
  • 刊出日期:  2025-07-04

目录

    /

    返回文章
    返回
    x 关闭 永久关闭